Sinus delivery of sustained release therapeutics
First Claim
1. A method for delivering at least a portion of a drug-releasing implant into a paranasal sinus having a paranasal sinus cavity comprising:
- a) enlarging an ostium of the paranasal sinus;
b) subsequently accessing the paranasal sinus cavity through the enlarged ostium with a delivery device loaded with the drug-releasing implant; and
c) delivering at least a portion of the drug-releasing implant into the paranasal sinus cavity,wherein the drug-releasing implant comprises a therapeutic amount of an active agent.
2 Assignments
0 Petitions
Accused Products
Abstract
The invention provides biodegradable implants for treating sinusitis. The biodegradable implants have a size, shape, density, viscosity, and/or mucoadhesiveness that prevents them from being substantially cleared by the mucociliary lining of the sinuses during the intended treatment period. The biodegradable implants include a sustained release therapeutic, e.g., an antibiotic, a steroidal anti-inflammatory agent, or both. The biodegradable implants may take various forms, such as rods, pellets, beads, strips, or microparticles, and may be delivered into a sinus in various pharmaceutically acceptable carriers.
-
Citations
42 Claims
-
1. A method for delivering at least a portion of a drug-releasing implant into a paranasal sinus having a paranasal sinus cavity comprising:
-
a) enlarging an ostium of the paranasal sinus; b) subsequently accessing the paranasal sinus cavity through the enlarged ostium with a delivery device loaded with the drug-releasing implant; and c) delivering at least a portion of the drug-releasing implant into the paranasal sinus cavity, wherein the drug-releasing implant comprises a therapeutic amount of an active agent. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40)
-
-
41. A method for delivering a drug-releasing implant into a paranasal sinus having a paranasal sinus cavity comprising:
-
a) enlarging an ostium of the paranasal sinus; b) subsequently accessing the paranasal sinus cavity through the enlarged ostium with a delivery device loaded with the drug-releasing implant; and c) delivering the drug-releasing implant into the paranasal sinus cavity, wherein the drug-releasing implant comprises a therapeutic amount of an active agent for the treatment of sinusitis.
-
-
42. A method for delivering a drug-releasing implant into a paranasal sinus having a paranasal sinus cavity comprising:
-
a) enlarging an ostium of the paranasal sinus; b) subsequently accessing the paranasal sinus cavity through the enlarged ostium with a delivery device loaded with the drug-releasing implant; and c) delivering the drug-releasing implant into the paranasal sinus cavity, wherein the drug-releasing implant comprises a therapeutic amount of an active agent for the reduction of inflammation.
-
Specification